Ignite Creation Date:
2024-07-17 @ 10:44 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06482788
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2024-05-22
Brief Title:
Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy Adebrelimab Combined With Chemotherapy XELOX a Prospective Single-center Feasibility Study
Organization:
Ruijin Hospital